Thymidine Market - Global Outlook and Forecast 2023-2028

Report ID: 1029929 | Published Date: Jan 2025 | No. of Page: 77 | Base Year: 2024 | Rating: 3.7 | Webstory: Check our Web story

Thymidine (deoxythymidine; other names deoxyribosylthymine, thymine deoxyriboside) is a pyrimidine deoxynucleoside. It is a pharmaceutical intermediate that used to make anti-AIDS drugs Zidovudine.
This report contains market size and forecasts of Thymidine in global, including the following market information:
Global Thymidine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Thymidine Market Sales, 2017-2022, 2023-2028, (MT)
Global top five Thymidine companies in 2021 (%)
The global Thymidine market was valued at 94 million in 2021 and is projected to reach US$ 114.2 million by 2028, at a CAGR of 2.9% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Chemical Synthesis Method Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Thymidine include Lonza, Carbopharm GmbH, Zhejiang NHU, Zhejiang Xianfeng Science Technology, Anhui Golden Sun Biopharmaceuticals, Hebei Anminuo, Ducheng and Chengzhi, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Thymidine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Thymidine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Thymidine Market Segment Percentages, by Type, 2021 (%)
Chemical Synthesis Method
Fermentation Method
Global Thymidine Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Thymidine Market Segment Percentages, by Application, 2021 (%)
Zidovudine
Other
Global Thymidine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Thymidine Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Thymidine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Thymidine revenues share in global market, 2021 (%)
Key companies Thymidine sales in global market, 2017-2022 (Estimated), (MT)
Key companies Thymidine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Lonza
Carbopharm GmbH
Zhejiang NHU
Zhejiang Xianfeng Science Technology
Anhui Golden Sun Biopharmaceuticals
Hebei Anminuo
Ducheng
Chengzhi

Frequently Asked Questions
Thymidine Market In Global report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Thymidine Market In Global report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Thymidine Market In Global report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports